Results 111 to 120 of about 42,221 (227)
Maternal propranolol as a safe alternative to invasive fetal surgery in chorioangioma management
Ultrasound in Obstetrics &Gynecology, Volume 68, Issue 2, Page 284-288, August 2026.ABSTRACT Chorioangiomas are associated with a significant risk of fetal demise due to high‐output cardiac failure. Standard invasive treatment, including fetoscopic laser photocoagulation and intratumoral embolization, shows limited success and has high fetal mortality rates.
L. E. van der Meeren +5 more
wiley +1 more source
Refractory Ulcerated Infantile Hemangioma Successfully Treated With Bleomycin Sclerotherapy: A Case Report. [PDF]
Am J Case RepAlghasham NM +3 more
europepmc +1 more source
British Journal of Pharmacology, Volume 183, Issue 15, Page 4091-4110, August 2026.Abstract Catecholamines are classically viewed as neuronal transmitters and adrenal hormones; however, accumulating evidence demonstrates that sources other than nerve fibres and adrenal medulla play a fundamental role in local organ regulation. Physiological paradoxes, such as preserved organ function after denervation or transplantation, challenge a ...
Mariana G. de Oliveira +3 more
wiley +1 more source
Long-term follow-up of height and weight after propranolol treatment for infantile hemangiomas. [PDF]
JAAD IntSun J, Zhao R, Huo R, Bi J, Li Z, Li X.
europepmc +1 more source
The Journal of Clinical Hypertension, Volume 28, Issue 8, August 2026.ABSTRACT Renal artery variations are recognized as potential contributors to hypertension through altered renal perfusion and activation of renin–angiotensin system. However, their clinical and hemodynamic significance in children remains unclear. This retrospective study included 14 pediatric patients (0–18 years) with hypertension and renal artery ...
Mehmet Baha Aytac +7 more
wiley +1 more source
Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives. [PDF]
Dermatol Ther (Heidelb)Nolan B, O'Connor C.
europepmc +1 more source
Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes
Liver International, Volume 46, Issue 8, August 2026.ABSTRACT Background and Aims The sympathetic nervous system is involved in the progression and aggressiveness of several cancers, including hepatocellular carcinoma (HCC). However, the specific effects of sympathetic innervation and catecholamines on tumour hepatocyte behaviour remain poorly understood.
Elise Lelou +14 more
wiley +1 more source
Liver International, Volume 46, Issue 8, August 2026.ABSTRACT Background The acute hepatic venous pressure gradient (HVPG)‐response to i.v. propranolol predicts outcomes in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH). While non‐invasive tests (NIT) to monitor non‐selective beta‐blocker (NSBB)‐induced HVPG changes are lacking, spleen stiffness ...
Paul Thöne +14 more
wiley +1 more source
Veterinary Dermatology, Volume 37, Issue 4, Page 530-533, August 2026.ABSTRACT A 5‐year‐old female cat presented with a purple depressed lesion on a metatarsal pad inducing ulceration and pain. Histopathological results revealed a non‐neoplastic vascular proliferation, a rare condition in cats. Topical beta‐blocker successfully prevented recurrence of ulceration.
Adrien Accard +6 more
wiley +1 more source
Propranolol monotherapy versus combined propranolol-gabapentin for prevention of paroxysmal sympathetic hyperactivity after moderate-severe traumatic brain injury: a randomized controlled trial. [PDF]
BMC AnesthesiolNegm EM +6 more
europepmc +1 more source